Manish Maski

478 total citations
18 papers, 259 citations indexed

About

Manish Maski is a scholar working on Physiology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Manish Maski has authored 18 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 5 papers in Organic Chemistry and 4 papers in Epidemiology. Recurrent topics in Manish Maski's work include Lysosomal Storage Disorders Research (8 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Trypanosoma species research and implications (4 papers). Manish Maski is often cited by papers focused on Lysosomal Storage Disorders Research (8 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Trypanosoma species research and implications (4 papers). Manish Maski collaborates with scholars based in United States, Spain and France. Manish Maski's co-authors include S. Ananth Karumanchi, S Bajracharya, Dongsheng Zhang, Sarosh Rana, Saira Salahuddin, Julia Wenger, Sajid Shahul, Ravi Thadhani, Ellen W. Seely and Larry A. Weinrauch and has published in prestigious journals such as Circulation, PLoS ONE and Journal of the American Society of Nephrology.

In The Last Decade

Manish Maski

17 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manish Maski United States 7 109 88 67 55 46 18 259
N. I. Tapilskaya Russia 9 122 1.1× 74 0.8× 25 0.4× 46 0.8× 86 1.9× 54 299
B. Casalino Italy 8 192 1.8× 183 2.1× 41 0.6× 73 1.3× 84 1.8× 9 379
Jackeline de Souza Rangel Machado Brazil 11 249 2.3× 149 1.7× 21 0.3× 63 1.1× 24 0.5× 25 334
Jorge Valencia‐Ortega Mexico 11 234 2.1× 134 1.5× 28 0.4× 18 0.3× 74 1.6× 23 362
Dongyu Wang China 10 242 2.2× 117 1.3× 20 0.3× 18 0.3× 122 2.7× 31 481
Anila Jaleel Pakistan 9 120 1.1× 71 0.8× 45 0.7× 25 0.5× 25 0.5× 34 293
Martina Gaggl Austria 10 26 0.2× 12 0.1× 72 1.1× 29 0.5× 45 1.0× 39 316
Lewis Renshall United Kingdom 10 298 2.7× 260 3.0× 33 0.5× 38 0.7× 51 1.1× 18 412
Ö. Karaçay Türkiye 6 162 1.5× 176 2.0× 26 0.4× 9 0.2× 63 1.4× 6 389
Radzisław Mierzyński Poland 11 192 1.8× 125 1.4× 23 0.3× 23 0.4× 41 0.9× 35 335

Countries citing papers authored by Manish Maski

Since Specialization
Citations

This map shows the geographic impact of Manish Maski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manish Maski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manish Maski more than expected).

Fields of papers citing papers by Manish Maski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manish Maski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manish Maski. The network helps show where Manish Maski may publish in the future.

Co-authorship network of co-authors of Manish Maski

This figure shows the co-authorship network connecting the top 25 collaborators of Manish Maski. A scholar is included among the top collaborators of Manish Maski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manish Maski. Manish Maski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Maski, Manish, et al.. (2025). Trends in chronic kidney disease and calories from ultra-processed foods: NHANES at the highly granular level. Discover Public Health. 22(1). 1 indexed citations
2.
Maski, Manish, et al.. (2025). Ultra-Processed Food and Chronic Kidney Disease Risk: A Systematic Review, Meta-Analysis, and Recommendations. Nutrients. 17(9). 1560–1560. 1 indexed citations
3.
Batista, Julie L., Ali Hariri, Manish Maski, et al.. (2024). Reduction in kidney function decline and risk of severe clinical events in agalsidase beta–treated Fabry disease patients: a matched analysis from the Fabry Registry. Clinical Kidney Journal. 17(8). sfae194–sfae194. 4 indexed citations
4.
Kulkarni, Yogesh A., et al.. (2024). Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review. BioDrugs. 38(6). 795–819. 14 indexed citations
5.
Lin, Julie, Anqi Hu, Shiguang Liu, et al.. (2024). "RESULT" Umbrella Trial in Primary Focal Segmental Glomerulosclerosis/Minimal Change Disease. Journal of the American Society of Nephrology. 35(10S).
6.
Antunes, Murillo de Oliveira, Juan Pablo Costabel, Juan Esteban Gómez‐Mesa, et al.. (2024). Multinational experience with next-generation sequencing: opportunity to identify transthyretin cardiac amyloidosis and Fabry disease. Cardiovascular Diagnosis and Therapy. 14(2). 294–303. 1 indexed citations
7.
Pisani, Antonio, Kathryn M. Wilson, Julie L. Batista, et al.. (2024). Clinical outcomes in patients switching from agalsidase beta to migalastat: A Fabry Registry analysis. Journal of Inherited Metabolic Disease. 47(5). 1080–1095. 2 indexed citations
8.
Pisani, Antonio, Kathryn M. Wilson, Julie L. Batista, et al.. (2024). Clinical outcomes in patients switching from agalsidase beta to migalastat: A Fabry Registry analysis. Molecular Genetics and Metabolism. 141(2). 107999–107999. 1 indexed citations
9.
Kabadi, Shaum, et al.. (2023). Cluster analysis of kidney function decline among males with Fabry disease in a large United States electronic health records database. Nephrology Dialysis Transplantation. 38(10). 2350–2357. 3 indexed citations
10.
Wanner, Christoph, Alberto Ortíz, William R. Wilcox, et al.. (2023). Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry community. Molecular Genetics and Metabolism. 139(3). 107603–107603. 18 indexed citations
11.
Batista, Julie L., Kathryn M. Wilson, Pronabesh DasMahapatra, et al.. (2023). Progression of left ventricular mass (LVM) is associated with clinical events in Fabry disease: Analyses from Fabry Registry. Molecular Genetics and Metabolism. 138(2). 107023–107023. 1 indexed citations
12.
Tøndel, Camilla, Beth L. Thurberg, Pronabesh DasMahapatra, et al.. (2022). Clinical relevance of globotriaosylceramide accumulation in Fabry disease and the effect of agalsidase beta in affected tissues. Molecular Genetics and Metabolism. 137(4). 328–341. 14 indexed citations
13.
Ortíz, Alberto, Steve Kanters, Alaa Hamed, et al.. (2020). Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis. Clinical Kidney Journal. 14(4). 1136–1146. 17 indexed citations
14.
Maski, Manish, Robert J. Thomas, S. Ananth Karumanchi, & Samir M. Parikh. (2016). Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Obstructive Sleep Apnea. PLoS ONE. 11(5). e0154503–e0154503. 4 indexed citations
15.
Horváth, Rita, Manish Maski, Zsuzsanna K. Zsengellér, et al.. (2016). 15 Follistatin-Like 3 Protein (FSTL3) is upregulated in preeclampsia. Pregnancy Hypertension. 6(3). 144–144. 4 indexed citations
16.
Ghosh, Chandra C., Kristina Thamm, Claudia Schrimpf, et al.. (2015). Drug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis*. Critical Care Medicine. 43(7). e230–e240. 36 indexed citations
17.
Maski, Manish, S Bajracharya, Julia Wenger, et al.. (2015). Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation. 132(18). 1726–1733. 119 indexed citations
18.
Weinrauch, Larry A. & Manish Maski. (2009). Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney. International Journal of Nephrology and Renovascular Disease. 2. 39–39. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. I. Tapilskaya Breakdown of academic impact, for papers by B. Casalino Breakdown of academic impact, for papers by Jackeline de Souza Rangel Machado Breakdown of academic impact, for papers by Jorge Valencia‐Ortega Breakdown of academic impact, for papers by Dongyu Wang Breakdown of academic impact, for papers by Anila Jaleel Breakdown of academic impact, for papers by Martina Gaggl Breakdown of academic impact, for papers by Lewis Renshall Breakdown of academic impact, for papers by Ö. Karaçay Breakdown of academic impact, for papers by Radzisław Mierzyński
Rankless by CCL
2026